- Home
- CET vs TLRY Comparison
CET vs TLRY Comparison
Compare CET & TLRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CET
- TLRY
- Stock Information
- Founded
- CET 1929
- TLRY N/A
- Country
- CET United States
- TLRY Canada
- Employees
- CET N/A
- TLRY N/A
- Industry
- CET Finance/Investors Services
- TLRY Medicinal Chemicals and Botanical Products
- Sector
- CET Finance
- TLRY Health Care
- Exchange
- CET Nasdaq
- TLRY Nasdaq
- Market Cap
- CET 1.5B
- TLRY 1.7B
- IPO Year
- CET N/A
- TLRY 2018
- Fundamental
- Price
- CET $48.71
- TLRY $0.96
- Analyst Decision
- CET
- TLRY Buy
- Analyst Count
- CET 0
- TLRY 3
- Target Price
- CET N/A
- TLRY $1.50
- AVG Volume (30 Days)
- CET 62.5K
- TLRY 47.5M
- Earning Date
- CET 01-01-0001
- TLRY 01-09-2026
- Dividend Yield
- CET 4.74%
- TLRY N/A
- EPS Growth
- CET N/A
- TLRY N/A
- EPS
- CET 7.40
- TLRY N/A
- Revenue
- CET $27,062,484.00
- TLRY $830,766,000.00
- Revenue This Year
- CET N/A
- TLRY $7.32
- Revenue Next Year
- CET N/A
- TLRY $4.49
- P/E Ratio
- CET $6.55
- TLRY N/A
- Revenue Growth
- CET 15.78
- TLRY 2.31
- 52 Week Low
- CET $40.24
- TLRY $0.35
- 52 Week High
- CET $52.44
- TLRY $2.32
- Technical
- Relative Strength Index (RSI)
- CET 34.88
- TLRY 33.79
- Support Level
- CET $47.92
- TLRY $0.88
- Resistance Level
- CET $49.64
- TLRY $1.33
- Average True Range (ATR)
- CET 1.04
- TLRY 0.08
- MACD
- CET -0.27
- TLRY -0.03
- Stochastic Oscillator
- CET 17.10
- TLRY 18.62
About CET Central Securities Corporation
Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital. The company invests in common stocks, bonds, convertible bonds, preferred stocks, convertible preferred stocks, warrants, options real estate, or short-term obligations of governments, banks, and corporations.
About TLRY Tilray Brands Inc.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure comes mostly from alcohol.